Variables | Total (n = 43) | Active UGIB (n = 7) | Inactive UGIB (n = 36) | p-value |
---|---|---|---|---|
Treatment | ||||
PRC (units) | ||||
Mean ± SD | 2.3 ± 2.8 | 5.1 ± 4.8 | 1.8 ± 1.9 | 0.003 |
Median (IQR) | 1.0 (0.0,4.0) | 4.0 (1.0,10.0) | 1.0 (0.0,3.0) | |
CTA with embolization, n(%) | 3 (7.0) | 3 (42.9) | 0 (0.0) | < 0.001 |
Endoscopic findings, n(%) | n = 17 | n = 6 | n = 11 | 0.328 |
Gastroduodenal ulcer | 11 (64.7) | 5 (83.3) | 6 (54.5) | |
Gastritis | 3 (17.6) | 0 | 3 (27.3) | |
Esophagitis | 1 (5.9) | 0 | 1 (9.1) | |
Gastric lymphoma | 1 (5.9) | 1 (16.7) | 0 | |
Normal (EGD, colonoscopy) | 1 (5.9) | 0 | 1 (9.1) | |
HP positive, n(%) | 3/17 (17.6) | 2/6 (33.3) | 1/11 (9.1) | < 0.001 |
Outcomes | ||||
Expired, n(%) | 17 (39.5) | 2 (28.6) | 15 (41.7) | 0.551 |
GIB-related death, n(%) | 1 (2.3) | 1 (14.3) | 0 | < 0.001 |
LOS (days) | ||||
Mean ± SD | 31.7 ± 30.6 | 18.4 ± 14.0 | 34.2 ± 32.4 | 0.215 |
Median (IQR) | 25.0 (14.0,37.0) | 14.0 (6.0,33.0) | 25.0 (15.0,45.0) |